CDK2-IN-31
CDK2-IN-31 (compound I-125A) is a CDK2 inhibitor. CDK2-IN-31 can be used in cancer research[1].
Product Specifications
CAS Number
2813260-27-2
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk2-in-31.html
Purity
98.22
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C[C@@H](OCCC1CCCCC1)[C@@H](C(NC)=O)NC([C@H]2C3(CN(C2)C(C4=CN(N=C4)CC5=CC=CC=C5)=O)CN(C3)C([C@@H]6C(C)(C6)C)=O)=O
Molecular Formula
C37H52N6O5
Molecular Weight
660.85
References & Citations
[1]Yuanjin Zhang, et al. An allosteric cyclin E-CDK2 site mapped by paralog hopping with covalent probes. Nat Chem Biol. 2024 Sep 18.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881879-100 1x 100 µL
Bcl-2 (Apoptosis & Follicular Lymphoma Marker) (rBCL2/796), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC883243-100 1x 100 µL
Dystrophin (DMD) (Marker of Duchenne and Becker Muscular Dystrophy) (DMD/3243), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 